✦ LIBER ✦

No augmentation during opioid treatment in restless legs syndrome – Results from a 1 year long-term trial

✍ Scribed by Kohnen, R.; Bosse, B.; Hopp, M.; Winkelmann, J.; Allen, R.; Trenkwalder, C.

Book ID: 122134230
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 35 KB
Volume: 14
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2013.11.402

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sleep in restless legs syndrome improves

Sleep in restless legs syndrome improves during opioid treatment – Results from a large 1-year multi-center trial

✍ Benes, H.; Trenkwalder, C.; Garcia-Borreguero, D.; Bosse, B.; Hopp, M.; Kohnen, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Progressive development of augmentation

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

✍ Birgit Högl; Diego García-Borreguero; Ralf Kohnen; Luigi Ferini-Strambi; Georgio 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 262 KB

Systematic evaluation of augmentation du

Systematic evaluation of augmentation during treatment with ropinirole in restless legs syndrome (Willis-Ekbom Disease): Results from a prospective, multicenter study over 66 weeks

✍ Diego García-Borreguero; Birgit Högl; Luigi Ferini-Strambi; John Winkelman; Chri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 915 KB

## Abstract The purpose of this study was to evaluate the incidence of augmentation over 66 weeks of treatment with ropinirole in patients with primary restless legs syndrome (RLS). Augmentation is the main complication of long‐term dopaminergic treatment of RLS. Despite widespread use of ropinirol